Company: TVRD
Filing Date: 2025-05-30
Form Type: S-1
Source: 0001104659-25-054853
Chunk: 314

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-05-30
Form: S-1
Chunk 314
---
 Interest rate (risk-free)                            |     |   4.37 | % |
| Conversion discount rate                             |     |  20.00 | % |

In addition to the inputs in the table, the Company’s assumptions and estimates incorporated into the valuation included probabilities assigned to each of the scenarios above, including a Qualified/non-Qualified financing (as defined in Note 8, Convertible Notes), IPO, reverse merger, and dissolution. Refer to Note 8, Convertible Notes, for further details surrounding the Qualified/non-Qualified Financing, IPO, reverse merger, and other settlement scenarios.

4.Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following as of December 31, 2024 and 2023 (in thousands):

| ​                                               
 ​                                               | ​ 
 ​ 
 ​ | ​                  
 As of December 31, |    ​ 
 2024 | ​ | ​ |     ​ 
  2023 |
|:------------------------------------------------|:--|:-------------------|-----:|:--|:--|------:|
| Prepaid research and development expenses       | ​ | $                  |   18 | ​ | $ | 3,203 |
| Other prepaid expenses                          | ​ |                    |   54 | ​ |   |    36 |
| Total prepaid expenses and other current assets | ​ | $                  |   72 | ​ | $ | 3,239 |

5.Intangible Assets

Intangible assets consisted of the following as of December 31, 2024 and 2023 (in thousands):

| ​                              
 ​                              | ​ 
 ​ 
 ​ | ​                  
 As of December 31, |    ​ 
 2024 | ​ | ​ |    ​ 
 2023 |
|:-------------------------------|:--|:-------------------|-----:|:--|:--|-----:|
| Licensed patent rights         | ​ | $                  |  826 | ​ | $ |  826 |
| Less: accumulated amortization | ​ |                    | -441 | ​ |   | -378 |
| Total intangible assets, net   | ​ | $                  |  385 | ​ | $ |  448 |

As of December 31, 2024, the expected remaining amortization expense is as follows (in thousands):

| ​                       
 Year Ended December 31, 
 2025                    | ​ | ​      
 Amount 
 ​      |   ​